The recent divergence among US-listed international and technology equities has sent the strongest signal yet that global capital flows are aggressively repositioning around two dominant themes: the infrastructure build-out for artificial intelligence and the fundamental rewiring of cross-border supply chains. Against the backdrop of shifting trade dynamics, investors are carefully weighing the downside risks to consumer-facing platforms, while assigning a durable premium to hardware and energy assets.

The core tension traversing this cohort is a meeting-by-meeting assessment of whether the relentless pace of AI capital expenditure can translate into near-term commercial viability, and how escalating trade frictions will reshape the earnings power of multinational tech giants listed in New York.

As the foundational layer of the global compute value chain, semiconductor and energy networks have cemented their strategic dominance in early 2026. SK Hynix (SKHYV.US), a critical DRAM and NAND supplier for global tech leaders, has demonstrated notable resilience and outperformed its broader sector, functioning as an indispensable node in the US-Asia semiconductor corridor. Similarly benefiting from the optical communication demands of AI data centers, Sivers Semiconductors (SIVEF.US) recently completed a SEK 700 million directed share issue in June 2026 to scale its InP laser manufacturing capacity—a capital-intensive expansion emblematic of the current hardware supercycle.

Ultimately, the computation arms race is bounded by energy and material security. Although NuScale Power (SMR.US) reported a steep revenue decline to USD 565,000 in the first quarter of 2026, the company exited the period with USD 1 billion in liquidity. Its ongoing collaboration with the Tennessee Valley Authority (TVA) for up to 6 gigawatts of advanced small modular reactor (SMR) capacity underscores its role as a proxy for next-generation AI power demands. On the materials front, MP Materials (MP.US), operating the largest rare earth processing facility in the Western Hemisphere, remains at the nexus of the critical minerals reshoring effort, drawing sustained interest from long-term capital allocators.

In the realm of applied AI and enterprise software, market preference leans heavily toward tangible commercialization. Tempus AI (TEM.US), which successfully raised USD 410.7 million in its 2024 IPO, is projected to reach USD 380 million in Q2 2026 revenue—a 20.6% year-over-year jump that highlights the robust monetization of precision medicine data. Meanwhile, BlackBerry (BB.US) continues to reap the rewards of its structural pivot to cybersecurity and IoT. The company recorded an all-time high QNX revenue of USD 78.7 million in Q4 FY2026 and posted its eighth consecutive quarter of GAAP net income improvement, triggering a moderate year-to-date recovery in its shares.

Conversely, cross-border consumer and e-commerce titans confront a far more hostile macroeconomic environment. While Alibaba (BABA.US) posted a 38% surge in Cloud Intelligence revenue for the quarter ending March 2026—fueled by triple-digit growth in AI-related products—its core Chinese e-commerce margins remain compressed by fierce price competition. Pinduoduo (PDD.US) achieved USD 15.4 billion in Q1 2026 revenue, yet this failed to alleviate Wall Street's structural concerns, prompting multiple analyst downgrades amid a turbulent consumer backdrop. Xiaomi (XIACY.US) is actively diversifying away from smartphone saturation, reporting RMB 99.1 billion in Q1 2026 total revenue and rapidly launching 490 smart EV sales centers across mainland China to insulate itself from consumer electronic cycles.

Operating entirely outside the orbit of geopolitical trade frictions, Crinetics Pharmaceuticals (CRNX.US) tracks an independent trajectory. As a biotech firm focused on rare endocrine diseases, its valuation narrative remains anchored to clinical pipeline milestones rather than macroeconomic fluctuations.

Looking ahead, the downside risks to this diverse asset pool remain acutely tied to the upcoming regulatory and policy nodes in Washington and Beijing, as well as the durability of AI capex heading into the latter half of 2026. Until these uncertainties clear, the structural repricing of cross-border equities is set to continue.

This article does not constitute investment advice.